G3 Meets in Conversation with
Kim Fookes of Novartis
Tuesday, March 1, 2022 | 12pm EST
Planning for diversity and inclusion in global clinical trials doesn’t need to be complicated. Join us on March 1 and hear from Kim Fookes, Global Head, Diversity and Inclusion in Clinical Trials of Novartis in conversation with Allison McDougall, EVP of G3, where they will discuss the global landscape of clinical trials, common myths surrounding diversity and inclusion in medical product development, and key takeaways for establishing effective diversity strategies.
About Kim
Kim Fookes,
Global Head, Diversity and Inclusion in Clinical Trials of Novartis
Kim has 28+ years of experience working in clinical research. Prior to being named the Global Head of DICT, Kim was responsible for all US clinical trial deliverables across Novartis’ portfolio, including early and late phase across oncology and non-oncology. She joined Novartis from AbbVie where she was the Head of Site Management & Monitoring, overseeing Global Site Management. While at AbbVie, Kim also managed operations for the Global Medical Therapeutic Areas and US Medical Affairs. Prior to AbbVie, she worked at Takeda, TAP, CROs, and Site Research Centers. She received her undergrad in Biology from Valdosta State University and enjoys yoga, poker, and painting.
About G3 Meets
Learn More About G3 Life Sciences